849093-96-5

Basic information

• Product Name: L-Cysteine, S-(2-pyridinylmethyl)-N-[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-, methyl ester
• CAS NO: 849093-96-5
• Molecular Formula: C18H18F4N2O2S
• Molecular Weight: 402.413
• Mol File: 849093-96-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: L-Cysteine, S-(2-pyridinylmethyl)-N-[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Cysteine, S-(2-pyridinylmethyl)-N-[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-, methyl ester(849093-96-5)
• EPA Substance Registry System: L-Cysteine, S-(2-pyridinylmethyl)-N-[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-, methyl ester(849093-96-5)

Safety Data

• Hazardous Substances Data: 849093-96-5(Hazardous Substances Data)

Upstream product

• 6959-47-3 2-chloromethylpyridine hydrochloride 
• 1160850-37-2 methyl N-(tert-butoxycarbonyl)-S-(pyridin-2-ylmethyl)-L-cysteinate 
• 849093-95-4 S-(pyridin-2-ylmethyl)-Boc-L-cysteine 
• 890040-38-7 (R)-2-amino-3-(pyridin-2-ylmethyl-sulfanyl)-propionic acid methyl ester hydrochloride 
• 655-32-3 2,2,2-trifluoro-1-(4-fluorophenyl)ethanone 

Relevant articles and documents

SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.